|
|
 |
|
Viewing report
|
|
|
|
Bayer Schering Pharma AG (SHRGY) - Strategic Analysis Review
GlobalData, Sep 2010, Pages: 27
Bayer Schering Pharma AG (Bayer Schering) is a global pharmaceutical company, engaged in the development, manufacturing and selling of pharmaceutical products. It is also involved in the research for new drugs and therapies. The company markets its products in over 100 countries in four geographic regions including Europe, the US, Latin America and Asia. The company is a part of the Bayer Group and formerly known as Schering AG. Bayer Schering signed an agreement with Micromet, Inc. to acquire an exclusive portion on a specific BiTE antibody.
Bayer Schering Pharma AG Key Recent Developments
Jun 17, 2010: Bayer Partners With OncoMed To Develop Anti-Cancer Stem Cell Therapeutics
Jun 15, 2010: Bayer Sues Teva And Barr For False Advertising And Patent Infringement In Connection With Teva’s Generic Gianvi
Jun 03, 2010: TauRx Signs Collaborative R&D Agreement With Bayer Schering Pharma
May 17, 2010: Bayer Schering Pharma To Establish New US Innovation Center In San Francisco
Apr 22, 2010: Micromet Reaches Milestone Under Collaboration With Bayer Schering Pharma
Our Bayer Schering Pharma AG - Strategic Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Our summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
Note-: Some sections may be missing if data is unavailable for the company.
Reasons to buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with Our detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Customers who bought this item also bought
Bayer AG - Product Pipeline Review - H2 2011
Micromet, Inc. (MITI) - Financial and Strategic SWOT Analysis Review
Bayer Schering Pharma AG: PharmaVitae Profile
Bayer Schering Pharma AG - Strategy and SWOT Report
Bayer Schering Pharma AG: SWOT Analysis & Company Profile
Micromet, Inc. - Product Pipeline Review - Q1 2011
Micromet, Inc. - Product Pipeline Review - H2 2011
Micromet, Inc. - Product Pipeline Review - Q4 2010
TauRx Therapeutics Ltd - Product Pipeline Review - Q4 2010
Bayer AG Petrochemicals Capacity and SWOT Analysis
|
|
|
|
